在癌症-免疫相互作用中,T细胞衍生的小细胞外囊泡
Ma Janelle Chichoco Garcia1, Su Su Thae Hnit1, Elena Shklovskaya2
1School of Natural Sciences, Faculty of Science and Engineering, Macquarie University, Sydney, NSW, 2109, Australia.
Cancer immunology, immunotherapy : CII
|June 25, 2025
概括
大多数细胞释放的小细胞外囊泡 (sEVs) 介导通信. 从T细胞衍生的sEV (T-sEV) 在癌症免疫疗法中至关重要,强调需要了解它们的产生和作用.
科学领域:
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
- 纳米技术 纳米技术
背景情况:
- 小细胞外囊泡 (sEVs) 是参与细胞间通信的纳米粒子.
- 在激活时,T细胞分泌sEVs (T-sEVs),在细胞信号传递中发挥作用.
- 由于其在癌症免疫疗法中的潜力,T-sEV越来越受到认可.
研究的目的:
- 审查T细胞衍生的sEVs的生物发生和特性.
- 阐明T-sEVs在细胞间通信中的作用.
- 探索T-sEVs在癌症免疫治疗中的潜在应用.
主要方法:
- 对T-sEVs现有研究的文献综述.
- 对T-sEV生物发生和分泌机制的分析.
- 关于T-sEV功能在免疫反应和癌症中的数据综合.
主要成果:
- T-sEVs是免疫反应中细胞间通信的关键媒介.
- 有证据表明,T-sEV对于有效的癌症免疫疗法至关重要.
- 关于T-sEVs与瘤衍生的sEVs相比,文献中有一个空白.
结论:
- 了解T-sEV生物发生和功能对于推进癌症免疫疗法至关重要.
- T-sEVs代表了新型免疫治疗策略的有希望的途径.
- 对T-sEV进行进一步的研究是有必要的,以充分利用它们的治疗潜力.
更多相关视频
11:15A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
Published on: May 6, 2018
10.3K
10:33An Enrichment Method for Small Extracellular Vesicles Derived from Liver Cancer Tissue
Published on: February 3, 2023
1.4K
相关概念视频
The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Tumor Immunotherapy
675
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
675
Overview of Exosomes
2.9K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.9K
Metastasis
5.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.7K
Cancer Stem Cells and Tumor Maintenance
5.1K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.1K
